Top compounds associated with response to CILP2


Feature Type Standardized
Nominal ANOVA
mRNA GSK-1904529A GDSC1000 pan-cancer AAC -0.088 0.007
mRNA PHA-793887 CTRPv2 pan-cancer AAC 0.082 0.008
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.27 0.01
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.095 0.01
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.091 0.01
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.01
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.099 0.01
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC 0.11 0.02
Download CSV